Latest biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Time reconoce a HER2DX® como uno de los mejores inventos del 2022

by VHIO

1 year ago
HER2DX®, REVEAL GENOMICS, S.L.

HER2DX®️ es el primer test genómico en el mundo especializado en cáncer de mama HER2+ y es comercializado por REVEAL GENOMICS® desde enero de 2022, una spin-off en la que Vall d’Hebron Institu...

El HUB aborda en un NeuroDebate la actualidad de los biomarcadores de las patologías neurológicas

by Hospital Universitari de Bellvitge

1 year ago
Enfermedad de Motoneurona, atrofia muscular espinal (AME), alzheimer

Enfermedades de motoneurona, alzheimer, cefaleas y esclerosis múltiple han sido los cuatro grandes bloques del NeuroDebat, organizado por el Servicio de Neurología del Hospital Universitari de Bellv...

Xeltis starts pivotal clinical trial with first ever restorative synthetic hemodialysis access graft

by Ysios Capital

1 year ago
AXESS European pivotal trial, hemodialysis, Xeltis

The AXESS European pivotal trial is a prospective, single arm study to evaluate the safety and performance of aXess in patients with end-stage renal disease who need hemodialysis.

Aura Announces Global Phase 3 Trial Design with Suprachoroidal Route of Administration Based on Positive Phase 2 Interim Data of Belzupacap Sarotalocan in Early-Stage

by Ysios Capital

1 year ago
choroidal melanoma (CM), Aura Biosciences Inc, Belzupacap Sarotalocan

The trial will evaluate the efficacy and safety of belzupacap sarotalocan (bel-sar) with suprachoroidal administration, for the first-line treatment of early-stage choroidal melanoma (CM).

ibs.GRANADA scientists demonstrate the mechanism of action of melatonin to increase the death of head and neck cancer cells

by Instituto de Investigación Biosanitaria - Ibs Granada

1 year ago
head and neck squamous cell carcinoma (HNSCC), melatonin

The MP17-Intercellular Communication research group of the Granada Biosanitary Research Institute (ibs.GRANADA) has carried out a study that demonstrates the important role of melatonin, a hormone tha...

Living with varicose veins: tips to prevent the disease from progressing

by Fundació Clínic per a la Recerca Biomèdica

1 year ago
Varicose veins

There are several causes of varicose veins, such as advanced age, genetics, pregnancy, sedentary lifestyle and being overweight. Although varicose veins cannot always be prevented, following certain r...

Identification of the cells responsible for colon cancer relapse

by IRB Barcelona - Instituto de Investigación Biomédica

1 year ago
HRCs, colon cancer relapse

The study shows that early immunotherapy, before surgery, can eliminate these cells before they have started to develop a metastasis, and thus prevent relapse of the disease.

Relationship of environmental exposure to nitrogen oxide with the severity of rhinovirus infection

by Fundació Sant Joan de Déu

1 year ago
rhinovirus infection, Nitrogen oxides

Understanding how the environment influences respiratory virus infection severity, such as rhinovirus, can help to establish better policies to mitigate the nitrogen compounds production from fossil f...

Even Before Birth, Children Are More Vulnerable and Have More Health Problems Caused by Environmental Factors Than Adults

by ISGlobal - Instituto de Salud Global de Barcelona

1 year ago
FAROS

The latest FAROS report proposes interventions to ensure air quality in schools, where children spend most of their time, and to convert playgrounds into small natural spaces

Value-based medicine and Risk Sharing Agreement

by GENESIS Biomed

1 year ago
“Patient Value”, Risk sharement agreement

The development of more sophisticated and high-cost treatments with a high preponderance of advanced therapies suggests that this business model is expected to be imposed in more and more cases, imply...

ORYZON announces FDA clearance of IND to initiate a collaborative Phase II basket study with iadademstat in R/R patients with Neuroendocrine carcinomas (NECs)

by Oryzon Genomics

1 year ago
Oryzon Genomics S.A., Neuroendocrine neoplasms, Iadademstat

Oryzon Genomics S. A., announced today that the FDA has approved the Investigational New Drug (IND) application to initiate a Phase II collaborative study with iadademstat in patients with relapsed/re...

Demuestran la actividad antioxidante de proteínas obtenidas de gusanos de seda

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

1 year ago
gusanos de seda

Realizaron pruebas en el laboratorio y en células del hígado para conocer su respuesta al daño oxidativo. Los resultados apuntan a que este nuevo producto contiene sustancias que actúan protegiend...